Investors eyeing a purchase of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock, but tentative about paying the going market price of $14.27/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $11 strike, which has a bid at the time of this writing of $1.65. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock performance … Continue reading Drugs Generic: Neurocrine Biosciences (NASDAQ:NBIX), The Medicines Company (NASDAQ:MDCO), Avanir Pharmaceuticals (NASDAQ:AVNR), Horizon Pharma (NASDAQ:HZNP)